NEO212, temozolomide conjugated to perillyl alcohol, is a novel drug for effective treatment of a broad range of temozolomide-resistant gliomas. uri icon

authors

  • Cho, Hee-Yeon
  • Wang, Weijun
  • Jhaveri, Niyati
  • David Richard Lee, MD, MBA
  • Sharma, Natasha
  • Dubeau, Louis
  • Schönthal, Axel H
  • Hofman, Florence M
  • Chen, Thomas C

publication date

  • January 1, 2014